HSQY Plastic manufactures and supplies pharmaceutical PVC blister film and laminated medicinal packaging films for tablets, capsules, pills, suppositories, nutraceuticals, veterinary products and other qualified pharmaceutical applications.
Our pharmaceutical forming-film range includes rigid PVC film, PVC/PVDC film, PVC/PE film and PVC/PVDC/PE composite film. Clear, transparent tinted and opaque grades can be supplied with customized thickness, slit width, roll diameter, core size, winding configuration and barrier structure according to blister-packaging requirements.
Pharmaceutical blister material should be selected as part of the complete packaging system. The medicine's moisture, oxygen and light sensitivity, target shelf life, distribution climate, blister cavity geometry, forming machine, aluminum lidding foil and sealing conditions all influence the final material selection.
If you are developing or replacing a pharmaceutical blister film, send HSQY your current specification, film thickness, web width, machine model, cavity depth, barrier requirement and annual consumption. Our team can help identify suitable materials for sample and blister-line evaluation.
Pharmaceutical PVC blister film is normally a rigid, non-plasticized PVC forming web used to create cavities in thermoformed medicine blister packs. During packaging, the PVC film is heated, formed into cavities, filled with tablets or capsules and sealed to a compatible pharmaceutical lidding material, typically heat-seal-lacquered aluminum foil.
Plain rigid PVC is widely used because it provides good transparency, established thermoforming performance, useful rigidity and relatively economical packaging cost. However, standard PVC does not provide the same moisture and oxygen barrier as coated or laminated pharmaceutical films.
Moisture-sensitive, oxygen-sensitive or highly hygroscopic medicines may therefore require PVC/PVDC, PVC/PVDC/PE, PCTFE-based laminate, cold-form aluminum or another higher-barrier structure. Final selection should be supported by stability studies and packaging validation.
HSQY supplies several pharmaceutical forming-film structures for different dosage forms, cavity designs and barrier requirements.
| Film Structure | Main Characteristics | Typical Applications |
|---|---|---|
| Rigid PVC Pharmaceutical Film | Good clarity, established thermoforming performance and economical cost. Provides basic environmental protection. | Stable tablets, capsules, pills and other solid-dose products with moderate barrier requirements. |
| PVC/PVDC Coated Film | PVDC coating improves resistance to water vapor, oxygen and aroma transmission while maintaining thermoformability. | Moisture-sensitive tablets, capsules, nutraceuticals and products distributed in humid climates. |
| PVC/PE Composite Film | Combines PVC structural properties with a PE functional layer for selected sealing, forming or unit-dose applications. | Suppository packaging and selected pharmaceutical or healthcare packaging structures. |
| PVC/PVDC/PE Composite Film | Multilayer film providing enhanced environmental protection and specialized forming performance. | Hygroscopic products, deeper blister cavities and demanding packaging programs. |
| Colored Pharmaceutical PVC Film | Transparent tinted or opaque grades for identification, branding or controlled light transmission. | Product differentiation and selected light-sensitive medicines after stability evaluation. |
HSQY supplies several pharmaceutical film families with different thickness, web-width and roll configurations. The following values summarize common supply options. Final specifications should always be confirmed for the selected grade.
| Specification | Typical HSQY Options |
|---|---|
| Materials | Rigid PVC, PVC/PVDC, PVC/PE and PVC/PVDC/PE |
| Typical Pharmaceutical Thickness | Approximately 0.13 mm – 0.50 mm depending on film structure |
| Common Rigid PVC Range | Approximately 0.20 mm – 0.30 mm for many solid-dose blister applications |
| Common Reference Widths | 130 mm, 225 mm, 245 mm and 250 mm |
| Custom Slit Width | Available within production-line capability |
| Maximum Web Width | Approximately 800–1280 mm for selected structures before final slitting |
| Core Diameter | 76 mm available for selected roll products; other core specifications subject to confirmation |
| Maximum Roll Diameter | Up to approximately 600 mm for selected pharmaceutical film products |
| Colors | Clear, transparent blue tint, white, amber, red, green, yellow and customized colors |
| Surface | Smooth glossy surface for many blister grades; specialty surfaces subject to grade confirmation |
| Typical MOQ | Approximately 1000–2000 kg depending on structure, thickness, width, color and documentation requirements |
| Typical Lead Time | Approximately 7–15 days for selected standard specifications after technical and commercial confirmation |
Pharmaceutical blister film should be purchased against an approved specification. Thickness tolerance, slit width, roll diameter, core, winding direction, permitted splices, color, coating weight, appearance criteria and required quality documents should be defined before commercial production.
The best pharmaceutical blister film is not necessarily the material with the highest barrier. The correct structure provides enough protection to meet the product's validated shelf-life requirement while maintaining suitable forming performance and total packaging cost.
| Selection Factor | Rigid PVC | PVC/PVDC | PVC/PVDC/PE |
|---|---|---|---|
| Moisture Barrier | Basic | Improved according to PVDC coating | Enhanced depending on complete laminate structure |
| Oxygen Barrier | Limited compared with barrier-coated structures | Improved | Improved; final performance depends on structure |
| Thermoforming | Established and widely used | Good with suitable processing control | Useful for selected specialized or deeper forming applications |
| Relative Cost | Lower | Medium to higher | Higher due to multilayer construction |
| Typical Use | Stable oral solid-dose products | Moisture- or oxygen-sensitive medicines | Demanding products, selected deep cavities and specialized packs |
Film Unwinding: The pharmaceutical forming web is unwound under controlled tension.
Heating: The film passes through a controlled heating section until it reaches the required forming condition.
Thermoforming: Vacuum, pressure, plug assistance or a combination creates the blister cavities.
Product Filling: Tablets, capsules or other approved dosage forms are loaded into the formed cavities.
Lidding Application: Compatible pharmaceutical lidding foil is positioned over the blister web.
Heat Sealing: Temperature, pressure and dwell time activate the lidding foil's heat-seal lacquer.
Inspection and Coding: Product presence, print information and package quality are checked.
Punching: The continuous web is cut into finished blister cards.
The PVC film alone does not determine final package performance. The completed blister consists of the forming web, cavity geometry, dosage form, lidding material, sealing system and secondary packaging.
Consistent thickness, controlled shrinkage, uniform winding and accurate slitting are critical for pharmaceutical packaging lines. Variation in the film can cause web tracking, cavity formation, registration, sealing and punching problems.
When requesting sample material, buyers should provide the blister-machine manufacturer and model, forming system, web width, line speed, heating configuration, cavity depth, indexing length, forming direction and maximum roll dimensions.
Roll unwinding and web tracking
Film tension stability
Heating uniformity across the web
Cavity definition and corner formation
Wall-thickness distribution after forming
Film shrinkage and registration
Whitening, stress marks, bubbles or pinholes
Flange flatness before sealing
Heat-seal consistency
Punching accuracy and finished edges
Replacing an existing pharmaceutical blister film?
Send HSQY your current material specification, thickness, roll width, core size, PVDC coating weight, machine model and annual usage. We can review comparable options for trial production.
Request Comparable Pharma FilmRigid PVC blister film is commonly sealed to pharmaceutical push-through aluminum foil coated with a compatible heat-seal lacquer. Reliable sealing depends on both materials and the packaging-machine conditions.
Before commercial approval, buyers should evaluate the exact forming film and aluminum foil combination under the intended sealing temperature, pressure and dwell time.
Seal strength
Seal uniformity
Channel leakage
Lacquer compatibility
Foil delamination
Push-through performance
Storage and stability performance
Child-resistant, senior-friendly and tamper-evident performance are properties of the complete tested package design and should not be attributed to PVC film alone.
Pharmaceutical packaging must protect the medicine during its approved shelf life. Required barrier performance depends on the drug formulation, tablet coating, capsule shell, blister cavity size, film structure, climate, secondary packaging and distribution conditions.
Is the product sensitive to moisture?
Is the product sensitive to oxygen?
Is the product sensitive to light?
What is the required product shelf life?
What climatic zone will the product be distributed in?
What is the cavity depth and blister surface area?
Will secondary barrier packaging be used?
What barrier data are available from the existing pack?
Barrier values measured on flat film are useful for material screening, but thermoforming stretches and thins the material. Final package protection should therefore be verified using the actual formed blister configuration.
PVC/PVDC pharmaceutical film uses rigid PVC as the thermoforming substrate and a controlled PVDC coating to improve resistance to moisture, oxygen and aroma transmission.
Different PVDC coating weights can provide different barrier levels. Common industry configurations may include approximately 40, 60, 90 or 120 g/m², but availability and final selection should always be confirmed against the specific HSQY grade.
Higher coating weight should not be selected automatically. Required PVDC level depends on drug sensitivity, cavity geometry, forming draw, climate, shelf-life target and actual stability data.
Tablet Blister Packs: Unit-dose packaging for qualified compressed tablets.
Hard Capsule Blisters: Transparent or barrier packaging for hard-shell capsules.
Soft Capsule Blisters: Selected film structures after compatibility and stability evaluation.
Nutraceutical Packaging: Vitamins, dietary supplements and related unit-dose products.
Veterinary Products: Qualified tablets and capsules for veterinary pharmaceutical programs.
Clinical Trial Packs: Selected sample-dose and clinical-study blister formats.
Suppository Packaging: Specialized PVC/PE or multilayer structures according to product requirements.
Selected Healthcare Packaging: Non-sterile healthcare and diagnostic components after application-specific qualification.
Standard pharmaceutical PVC blister film should not automatically be described as a sterile barrier material. Sterile medical-device packaging requires specific material, seal-system, sterilization and microbial-barrier validation.
HSQY pharmaceutical PVC films can be supplied in different appearances according to product identification and packaging-design requirements.
| Appearance | Typical Purpose |
|---|---|
| Clear PVC | Maximum product visibility and visual inspection |
| Blue-Tinted Clear PVC | Product differentiation while maintaining transparency |
| Amber PVC | Reduced light transmission for selected applications subject to testing |
| Opaque White | Branding, identification and reduced direct product visibility |
| Custom Colors | Product coding and brand differentiation subject to formulation approval |
Visible color alone does not prove adequate light protection. Light-sensitive medicines require defined spectral-transmission requirements and supporting stability evaluation.
Pharmaceutical primary packaging requires controlled specifications, documented production and batch traceability. Testing depends on the material structure and agreed customer specification.
| Test Area | Typical Checks | Why It Matters |
|---|---|---|
| Material Identity | Composition, structure and approved raw materials | Confirms the correct qualified packaging material is supplied |
| Dimensions | Thickness, width, core size and roll dimensions | Affects machine setup and forming consistency |
| Visual Quality | Clarity, color, black spots, gels, bubbles and surface defects | Supports package appearance and uninterrupted production |
| Thermal Performance | Shrinkage and forming behavior | Supports cavity consistency and registration |
| Mechanical Properties | Impact, tensile and punching behavior where applicable | Supports handling and blister-card integrity |
| Barrier | WVTR, OTR and PVDC coating weight when applicable | Supports product-protection requirements |
| Seal Compatibility | Heat-seal behavior and seal-strength evaluation | Reduces weak seals and channel leaks |
| Chemical Safety | Applicable migration, residual, extractable or other safety testing | Supports packaging-material safety assessment |
There is no single certificate that automatically makes one PVC blister film suitable for every medicine and every market. The required documentation depends on the destination jurisdiction, dosage form, drug dossier and packaging-material specification.
Depending on the selected HSQY grade and customer requirements, documentation may include:
Certificate of Analysis for production batches
Technical Data Sheet
Material composition information
Declaration of conformity where applicable
Applicable pharmacopoeial testing information
Migration, extractables or chemical-safety information where applicable
WVTR, OTR or coating-weight data for barrier structures
Manufacturing-site and quality-management information
Batch traceability information
Change-control support subject to commercial agreement
Regulatory support documents subject to product grade and market requirements
Buyers should identify the destination market and required dossier support before placing an order. General reports such as ISO, REACH, RoHS or SGS documents do not by themselves replace pharmaceutical compatibility, stability and primary-packaging qualification.
| Problem | Possible Causes | Recommended Checks |
|---|---|---|
| Shallow or Incomplete Cavities | Insufficient heating, poor vacuum, short dwell or unsuitable film | Check actual web temperature, tooling, vacuum and film grade |
| Excessive Shrinkage | Overheating, unstable thermal characteristics or excessive heating time | Review heating profile and shrinkage specification |
| Web Tracking Problems | Uneven winding, variable thickness, poor slitting or tension imbalance | Check roll geometry, core alignment and web guides |
| Weak Heat Seal | Incorrect lacquer compatibility, sealing temperature or pressure | Test forming film, foil and sealing window together |
| Wrinkled Seal Area | Poor flange flatness, shrinkage or machine tension | Check forming temperature, tooling and tension control |
| Blister Cracking | Excessive draw, unsuitable material or poor temperature distribution | Review cavity design, film structure and forming process |
Automatic blister lines require more than the correct thickness. Roll geometry and winding quality directly affect production efficiency.
Exact slit width and width tolerance
Core inside diameter
Core material
Maximum roll outside diameter
Maximum roll weight
Winding direction
Coated-side orientation for multilayer films
Roll hardness and winding tension
Maximum acceptable number of splices
Roll and batch-label requirements
Keep rolls in their original protective packaging until required for production.
Store in a clean, dry and controlled warehouse environment.
Protect film from direct sunlight, moisture, dust and strong odors.
Avoid contact with corrosive chemicals or contamination sources.
Support rolls according to their packaging design to avoid edge damage.
Do not drag rolls across floors or handle the film by unsupported edges.
Follow agreed storage-life and conditioning recommendations for the selected grade.
Pharmaceutical PVC film is normally supplied in carefully wound rolls with protective packaging suitable for industrial handling and international shipment.
Protective PE film wrapping
Kraft-paper protection
Roll-end protection
Batch and roll identification
Export pallet packing
Customized roll weight
Customized pallet dimensions
Container-loading planning
Multiple Pharmaceutical Structures: Rigid PVC, PVC/PVDC, PVC/PE and PVC/PVDC/PE options.
Custom Film Thickness: Pharmaceutical forming-film specifications can be matched to packaging requirements.
Custom Slitting: Roll width can be matched to blister-machine web requirements.
Custom Roll Configuration: Core, roll diameter, roll weight and winding direction can be discussed.
Barrier Options: Standard PVC and PVDC-coated higher-barrier solutions are available.
Color Development: Clear, tinted and opaque pharmaceutical-film options.
Sample and Trial-Roll Support: Material can be evaluated on the customer's blister line before commercial approval.
Quality Documentation: Product and batch documents can be supplied according to the confirmed grade and agreement.
B2B Export Supply: Bulk roll and pallet supply for pharmaceutical packaging customers worldwide.
Need help choosing PVC or PVC/PVDC?
Provide the dosage form, stability requirements, target shelf life, climate zone, current blister structure and machine specification. HSQY can help identify suitable materials for evaluation.
Discuss Your Pharmaceutical Packaging ProjectA detailed RFQ allows HSQY to recommend and quote pharmaceutical blister material more accurately.
Dosage form: tablet, capsule, suppository or other product
Drug sensitivity to moisture, oxygen and light
Current packaging-film structure
PVC thickness
PVDC coating weight where applicable
Film width and tolerance
Core inside diameter
Maximum roll diameter and roll weight
Blister-machine manufacturer and model
Forming system and line speed
Cavity dimensions and draw depth
Blister-card layout
Lidding foil and heat-seal lacquer specification
Required barrier or stability target
Color and opacity requirements
Destination regulatory market
Required technical and regulatory documentation
Trial quantity
Commercial order quantity and annual demand
Packing and delivery requirements
Pharmaceutical PVC blister film is a rigid forming web used to thermoform cavities for tablets, capsules and other qualified unit-dose pharmaceutical products. The formed film is normally sealed to a compatible pharmaceutical lidding material.
Approximately 0.20–0.30 mm is common for many rigid PVC pharmaceutical blister applications. HSQY's pharmaceutical film range extends approximately from 0.13 mm to 0.50 mm depending on the selected structure.
Yes. Approximately 250 micron is a common reference thickness for rigid pharmaceutical PVC, but the correct gauge must be selected according to cavity geometry, blister tooling, dosage form and validated machine conditions.
Plain rigid PVC provides good thermoforming and clarity but relatively basic moisture and oxygen barrier. PVC/PVDC adds a PVDC coating that improves environmental barrier while maintaining the PVC forming substrate.
PVC/PVDC/PE is a multilayer pharmaceutical forming-film structure combining a PVC base with barrier and functional layers. It can be used for selected products requiring enhanced barrier or specialized forming performance.
No. Plain rigid PVC provides basic environmental protection but should not normally be classified as a high moisture- or oxygen-barrier material. Sensitive products may require PVDC-coated, PCTFE-based or aluminum-based structures.
PVDC coating should be selected according to drug sensitivity, shelf life, climate zone, blister geometry, forming draw and target moisture or oxygen barrier. Stability testing should confirm the final structure.
Yes. Rigid PVC blister film is commonly heat sealed to pharmaceutical aluminum lidding foil containing a compatible heat-seal lacquer. The exact foil, lacquer and sealing conditions must be validated together.
Options can include clear, transparent blue, white, amber, red, green, yellow and customized colors. Colorants and opacity must be appropriate for the selected pharmaceutical packaging application.
Colored or opaque material can reduce light transmission, but visible color alone does not prove sufficient light protection. Required spectral performance should be defined and verified through appropriate testing and stability studies.
PVC forming film alone is not child-resistant. Child resistance depends on the complete blister package design, lidding structure, opening mechanism and applicable finished-package testing.
Standard pharmaceutical blister film is not automatically supplied as sterile. Sterile packaging applications require a material and packaging process specifically designed and validated for the intended sterilization and sterile-barrier requirements.
Possible causes include insufficient heating, uneven temperature, poor vacuum or compressed air, excessive cavity depth, blocked mold vents, unsuitable film thickness, unstable web tension or an incorrect forming-film grade.
Depending on the specification, tests may include material identity, thickness, width, visual quality, color, haze, thermal shrinkage, forming performance, mechanical properties, barrier transmission, PVDC coating weight, seal compatibility, migration and other chemical-safety requirements.
No. ISO 9001 relates to quality-management systems. Pharmaceutical primary-packaging suitability also requires controlled material specifications, safety and compatibility information, performance testing, stability assessment and destination-market documentation.
Yes. HSQY can discuss customized film structure, thickness, PVDC coating, slit width, roll diameter, core, winding direction, color and packaging according to technical requirements and order quantity.
Many HSQY pharmaceutical film specifications have a typical MOQ of approximately 1000–2000 kg. Custom thicknesses, special colors, PVDC coating weights and documentation requirements may result in a different MOQ.
Trial material can be discussed for suitable projects. Pharmaceutical buyers should evaluate new film on the actual blister machine for forming, tracking, sealing, punching and finished-package performance before commercial approval.
Provide the film structure, thickness, width, core, roll diameter, PVDC coating weight if applicable, color, blister-machine model, cavity depth, lidding foil, regulatory market, required documentation, trial quantity and estimated annual demand.
HSQY supplies rigid PVC and higher-barrier pharmaceutical forming films to pharmaceutical packaging manufacturers, contract packers, drug manufacturers, distributors and industrial converters worldwide.
Whether you currently use 250 micron rigid PVC, PVC/PVDC or a multilayer pharmaceutical structure, HSQY can review your technical specification and provide suitable material options for testing.
Send us your current specification, blister-machine information and annual volume to request technical data, trial material, packaging information and bulk pricing.
Product Category
Let’s Find the Right Plastic Solution